• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜转移侵犯精囊:放射学表现及治疗结果。

Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment.

机构信息

Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, DC, USA.

出版信息

Eur J Surg Oncol. 2018 Jun;44(6):805-809. doi: 10.1016/j.ejso.2018.01.009. Epub 2018 Jan 12.

DOI:10.1016/j.ejso.2018.01.009
PMID:29428475
Abstract

BACKGROUND

Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) may be of greatest benefit if all visible evidence of disease is resected. In some male patients the peritoneal metastases within the pelvis are invasive into the seminal vesicles and complete cytoreduction requires resection of these structures.

PATIENTS AND METHODS

From a prospective database of colorectal and appendiceal cancer patients who had CT evidence of seminal vesicle involvement and then had cytoreduction including resection of the seminal vesicles were reviewed. Their clinical features were tabulated.

RESULTS

Five patients were identified between ages 52 and 60. Three of 5 were appendiceal mucinous neoplasms and 4 of 5 had complete cytoreduction. Two of the patients are long-term survivors of 120 and 28 months. All patients are impotent and reported no return of sexual function over time. All five patients report normal micturition.

CONCLUSIONS

Resection of the seminal vesicles in a patient with invasion of these structures by peritoneal metastases is possible and should be considered in selected patients. This resection causes impotence but normal urination is to be expected.

摘要

背景

如果切除所有可见的疾病证据,细胞减灭术 (CRS) 联合腹腔内热化疗 (HIPEC) 可能最有益。在一些男性患者中,盆腔内的腹膜转移灶侵犯精囊,要实现完全减瘤则需要切除这些结构。

患者与方法

从接受 CT 检查证实有精囊受累且随后接受包括切除精囊的细胞减灭术的结直肠和阑尾癌患者的前瞻性数据库中对这些患者进行了回顾性分析。他们的临床特征被列表记录。

结果

5 名患者的年龄在 52 岁至 60 岁之间。5 名患者中有 3 名患有阑尾黏液性肿瘤,5 名患者中有 4 名实现了完全减瘤。2 名患者为长期幸存者,生存时间分别为 120 个月和 28 个月。所有患者均丧失性功能且无性功能随时间恢复的报告。所有 5 名患者均报告正常排尿。

结论

对腹膜转移灶侵犯这些结构的患者进行精囊切除术是可行的,应在选择的患者中考虑这一手术。这种切除会导致阳痿,但预计排尿正常。

相似文献

1
Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment.腹膜转移侵犯精囊:放射学表现及治疗结果。
Eur J Surg Oncol. 2018 Jun;44(6):805-809. doi: 10.1016/j.ejso.2018.01.009. Epub 2018 Jan 12.
2
Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗后高级别阑尾或结直肠腹膜癌转移进展的预测因素
Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.
3
Psoas/iliacus muscle invasion from mucinous appendiceal neoplasm. Radiologic appearance and outcome of treatment in 3 patients.黏液性阑尾肿瘤侵犯腰大肌/髂肌。3例患者的影像学表现及治疗结果
Surg Oncol. 2018 Jun;27(2):154-157. doi: 10.1016/j.suronc.2018.02.002. Epub 2018 Feb 7.
4
Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗时代结直肠癌和阑尾癌卵巢转移的治疗
Eur J Surg Oncol. 2014 Aug;40(8):937-42. doi: 10.1016/j.ejso.2014.02.238. Epub 2014 Feb 28.
5
Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.极限细胞减灭术与热灌注腹腔化疗:来自单一三级中心的结果
Surg Oncol. 2015 Sep;24(3):264-9. doi: 10.1016/j.suronc.2015.06.013. Epub 2015 Jun 23.
6
Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.阑尾癌腹膜转移行细胞减灭术联合热灌注化疗后的生存预测及预后因素
Ann Surg Oncol. 2014 Dec;21(13):4218-25. doi: 10.1245/s10434-014-3869-1. Epub 2014 Jul 2.
7
The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.细胞减灭术和腹腔热灌注化疗(CRS/HIPEC)在高级阑尾癌和广泛腹膜癌病患者中的作用。
Ann Surg Oncol. 2012 Jan;19(1):110-4. doi: 10.1245/s10434-011-1840-y. Epub 2011 Jun 24.
8
The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).美国癌症联合委员会(AJCC)分期分类第7版与接受细胞减灭术和腹腔内热灌注化疗(CRS/HIPEC)治疗的伴有腹膜转移的黏液性阑尾肿瘤的生物学行为相关。
Ann Surg Oncol. 2016 Jun;23(6):1928-33. doi: 10.1245/s10434-015-5047-5. Epub 2015 Dec 29.
9
Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.高分级、大容量播散性黏液性阑尾肿瘤患者的细胞减灭术及热灌注腹腔内化疗的疗效
Ann Surg Oncol. 2016 Feb;23(2):382-90. doi: 10.1245/s10434-015-4838-z. Epub 2015 Oct 1.
10
Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis.阑尾癌病行细胞减灭术和腹腔热灌注化疗后的肿瘤学风险分层
Ann Surg Oncol. 2016 May;23(5):1587-93. doi: 10.1245/s10434-015-5037-7. Epub 2016 Jan 7.